Haruyo Watanabe

Impact of CYP2C19 Polymorphisms on the Antiplatelet Effect of Clopidogrel in an Actual Clinical Setting in Japan

Toshikazu Jinnai, Hisanori Horiuchi, Takeru Makiyama et al. · Circulation Journal · 2009 · 103 citations · Full text

Clopidogrel Resistance in Japanese Patients Scheduled forPercutaneous Coronary Intervention

Kozo Hoshino, Hisanori Horiuchi, Tomohisa Tada et al. · Circulation Journal · 2009 · 58 citations · Full text

Evaluation of the Antiplatelet Effects of Cilostazol, a Phosphodiesterase 3 Inhibitor, by VASP Phosphorylation and Platelet Aggregation

Hiromi Yamamoto, Kanako Takahashi, Haruyo Watanabe et al. · Circulation Journal · 2008 · 26 citations · Full text

Prediction of Clopidogrel Low Responders by a Rapid CYP2C19 Activity Test

Junichi Tazaki, Toshikazu Jinnai, Tomohisa Tada et al. · Journal of Atherosclerosis and Thrombosis · 2011 · 16 citations · Full text

Characterization of the Antiplatelet Effect of Aspirin at Enrollment and After 2-Year Follow-up in a Real Clinical Setting in Japan

Tomoyuki Ikeda, Ryoji Taniguchi, Shin Watanabe et al. · Circulation Journal · 2010 · 10 citations · Full text